SUVEN LIFE SCIENCES
Back to Balance Sheet
|
SUVEN LIFE SCIENCES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹135 Cr | ₹285 Cr | ₹483 Cr | ₹202 Cr | ₹222 Cr |
What is the latest Total Liabilities ratio of SUVEN LIFE SCIENCES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹135 Cr |
| Mar2024 | ₹285 Cr |
| Mar2023 | ₹483 Cr |
| Mar2022 | ₹202 Cr |
| Mar2021 | ₹222 Cr |
How is Total Liabilities of SUVEN LIFE SCIENCES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹135 Cr | -52.55 | |
| Mar2024 | ₹285 Cr | -40.99 | |
| Mar2023 | ₹483 Cr | 139.09 | |
| Mar2022 | ₹202 Cr | -9.17 | |
| Mar2021 | ₹222 Cr | - | |
Compare Total Liabilities of peers of SUVEN LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN LIFE SCIENCES | ₹3,518.3 Cr | -3.2% | 0.8% | 23.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,062.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,192.0 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,129.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,513.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,250.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
SUVEN LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN LIFE SCIENCES | -3.2% |
0.8% |
23.6% |
| SENSEX | -1% |
-0.1% |
7.9% |
You may also like the below Video Courses